Author

Zohar E. Ziff

National Institutes of HealthORCID 0009-0006-5822-026XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Daniel C. DouekiD· 2 shared Erin Maule· 2 shared Matthew GagnéiD· 2 shared Matthew R. Burnett· 2 shared Alan DodsoniD· 1 shared Alex Van RyiD· 1 shared Alexander C VostaliD· 1 shared Amy R. Henry· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Daniel C. DouekORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintFeb 5, 2026

Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines

Breanna Kim, Rachel Roenicke, P J Roeder…·Mark Connors

This study compares intranasal and intramuscular vaccines, finding that the intranasal Ad4-S vaccine provides more durable and effective immune responses against SARS-CoV-2 in preclinical models.

1 citation

mouseexperimental assay

𝕏 PostBluesky

ImmunologyNature ImmunologyPeer-reviewedSep 3, 2024

Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates

Matthew Gagné, Barbara J. Flynn, Shayne F. Andrew…·Robert A. Seder

This study shows that mucosal adenoviral-vectored vaccines provide durable protection against XBB.1.16 infection in nonhuman primates, outperforming intramuscular boosting in reducing virus replication in both upper and lower airways.

78 citationstop 1%

non-human primateexperimental assay

𝕏 PostBluesky